← Leaderboards
Walter Gerhard
Wistar Institute
$3,581,526
Attributed
$3,581,526
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $330.4K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$3,581,526 · 2
By mechanism
R01$3,581,526 · 2
Top collaborators
No co-investigators on record.
Most similar at Wistar Institute
Same institution · by research overlap
- David B. Weiner$32,577,386
- Andrew J Caton$12,366,195
- Scott Eric Hensley$9,126,326
- Dorothee M Herlyn$8,362,969
- Hui Hu$8,632,952
Others in their field
Top investigators on “Immunologic Memory”
- Ronald T Mitsuyasu · University Of California Los Angeles$100,063,564
- Rafi Ahmed · Emory University$59,047,469
- Olaf Schneewind · University Of California Los Angeles$51,261,752
- Mary A Staat · Children'S Hospital Med Ctr (Cincinnati)$29,892,220
- Rafick-Pierre Sekaly · University Of Montreal$29,092,711
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
Research focus
Immunologic MemoryInfluenzavirus ALaboratory MouseAntiviral AntibodyScid MouseHumoral ImmunityGene MutationGenetically Modified AnimalsHelper T LymphocyteImmunoglobulin AImmunoglobulin GImmunoglobulin MInfluenza VaccinesNeutralizing AntibodyPassive ImmunizationVirus ProteinAntibody FormationAntibody SpecificityB LymphocyteCross ImmunityCytotoxic T LymphocyteVaccine DevelopmentAgingT Lymphocyte
Grant awards (12)
M2-BASED INFLUENZA TYPE A VIRUS VACCINE$330,441
R01 · FY2006 · AI · contact PI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE$273,289
R01 · FY2005 · AI
ANTIBODY RESPONSE IN INFLUENZA VIRUS INFECTION$379,810
R01 · FY2004 · AI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE$252,208
R01 · FY2004 · AI
ANTIBODY RESPONSE IN INFLUENZA VIRUS INFECTION$368,747
R01 · FY2003 · AI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE$248,276
R01 · FY2003 · AI
ANTIBODY RESPONSE IN INFLUENZA VIRUS INFECTION$358,007
R01 · FY2002 · AI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE$197,247
R01 · FY2002 · AI
ANTIBODY RESPONSE IN INFLUENZA VIRUS INFECTION$347,581
R01 · FY2001 · AI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE$240,862
R01 · FY2001 · AI
ANTIBODY RESPONSE IN INFLUENZA VIRUS INFECTION$347,690
R01 · FY2000 · AI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE$237,368
R01 · FY2000 · AI